International Journal of Infectious Diseases
Volume 12, Issue 4 , Pages 374-379, July 2008

Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality

  • Mustafa A. Çevik

      Affiliations

    • Infectious Diseases and Clinical Microbiology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
  • ,
  • Ayse Erbay

      Affiliations

    • Infectious Diseases and Clinical Microbiology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 312 4305464; fax: +90 312 4305393.
  • ,
  • Hürrem Bodur

      Affiliations

    • Infectious Diseases and Clinical Microbiology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
  • ,
  • Evrim Gülderen

      Affiliations

    • Infectious Diseases and Clinical Microbiology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
  • ,
  • Aliye Baştuğ

      Affiliations

    • Infectious Diseases and Clinical Microbiology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey
  • ,
  • Ayhan Kubar

      Affiliations

    • Department of Virology, Gulhane Military Medical Academy, Ankara, Turkey
  • ,
  • Esragül Akıncı

      Affiliations

    • Infectious Diseases and Clinical Microbiology Department, Ankara Numune Education and Research Hospital, Ankara, Turkey

Received 22 May 2007; received in revised form 16 August 2007; accepted 25 September 2007. published online 06 December 2007.

Corresponding Editor: Andy I.M. Hoepelman, Utrecht, The Netherlands

Summary 

Objective

To determine the predictors of fatality among patients with Crimean-Congo hemorrhagic fever (CCHF) based on epidemiological, clinical, and laboratory findings.

Methods

Among the patients with possible CCHF who were referred to Ankara Numune Education and Research Hospital (ANERH) from the surrounding hospitals between 2003 and 2006, those with IgM antibodies and/or reverse transcriptase-polymerase chain reaction (RT-PCR) results positive for CCHF virus in their blood, and who had received only supportive treatment, were included in the study.

Results

Sixty-nine patients with CCHF were admitted to ANERH from various cities of the northeastern part of the central region and southern parts of the Black Sea region of Turkey. Eleven (15.9%) patients died. Age, gender, days from the appearance of symptoms to admission, and initial complaints except bleeding were similar between fatal and non-fatal cases (p>0.05). Among the clinical findings, ecchymosis (p=0.007), hematemesis (p=0.030), melena (p<0.001), somnolence (p<0.001), and gingival bleeding (p=0.044) were more common among fatal cases. The mean platelet count was 47.569×109/l in non-fatal cases and 12.636×109/l in fatal cases (p=0.003). Among the fatal cases, the mean prothrombin time (PT; 18.4s vs. 13.4s; p<0.001) and the mean activated partial thromboplastin time (aPTT; 69.4s vs. 42.7s; p=0.001) were longer, and the mean alanine aminotransferase (ALT; 1688 vs. 293; p<0.001), mean aspartate aminotransferase (AST; 3028 vs. 634; p<0.001), mean lactate dehydrogenase (LDH; 4245 vs. 1141; p<0.001), mean creatine phosphokinase (CPK; 3016 vs. 851; p=0.004) levels and the mean international normalized ratio (INR; 1.38 vs. 1.1; p<0.001) were higher. In a Cox proportional hazards model, thrombocytopenia of ≤20×109/l (hazard rate (HR) 9.67; 95% confidence interval (CI) 1.16–80.68; p=0.036), a prolonged aPTT ≥60s (HR 11.62; 95% CI 2.40–56.27; p=0.002), existence of melena (HR 6.39; 95% CI 1.64–24.93; p=0.008), and somnolence (HR 6.30; 95% CI 1.80–22.09; p=0.004) were independently associated with mortality.

Conclusions

Thrombocytopenia of ≤20×109/l, a prolonged aPTT ≥60s, the existence of melena, and somnolence were independent predictors of fatality.

Keywords: Crimean-Congo hemorrhagic fever, Fatality

 

PII: S1201-9712(07)00199-3

doi:10.1016/j.ijid.2007.09.010

International Journal of Infectious Diseases
Volume 12, Issue 4 , Pages 374-379, July 2008